(19)

(11)

EP 2 872 127 A1

(12)

(43) Date of publication: 20.05.2015 Bulletin 2015/21 (21) Application number: 13739919.2 (22) Date of filing: 11.07.2013

(51) International Patent Classification (IPC):  A61K 31/155(2006.01) A61P 3/00(2006.01) A61K 31/366(2006.01) A61K 31/4178(2006.01) A61K 31/60(2006.01) A61K 31/40(2006.01) A61K 45/06(2006.01) A61K 31/401(2006.01) A61K 31/55(2006.01) (86) International application number: PCT/US2013/050142 (87) International publication number: WO 2014/011926 (16.01.2014 Gazette 2014/03)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME (30) Priority: 11.07.2012 US 201213547022 05.01.2013 US 201313734966 (71) Applicant: Elcelyx Therapeutics, Inc. San Diego, CA 92130 (US)	(72) Inventors: BARON, Alain, D. San Diego, CA 92130 (US) FINEMAN, Mark, S. San Diego, CA 92131 (US) BEELEY, Nigel, R. A. Solana Beach, CA 92075 (US) (74) Representative: Ricker, Mathias  Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Zweibrückenstrasse 5-7 80331 München 80331 München (DE)